INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 63 filers reported holding INSTIL BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $284 | -100.0% | 450,000 | 0.0% | 0.02% | -82.8% |
| Q3 2022 | $2,178,000 | +4.8% | 450,000 | 0.0% | 0.09% | -16.2% |
| Q2 2022 | $2,079,000 | -57.0% | 450,000 | 0.0% | 0.11% | -45.3% |
| Q1 2022 | $4,838,000 | -37.2% | 450,000 | 0.0% | 0.20% | -2.9% |
| Q4 2021 | $7,700,000 | -4.3% | 450,000 | 0.0% | 0.21% | +16.1% |
| Q3 2021 | $8,044,000 | -7.5% | 450,000 | 0.0% | 0.18% | +2.3% |
| Q2 2021 | $8,694,000 | -23.0% | 450,000 | 0.0% | 0.18% | -11.6% |
| Q1 2021 | $11,286,000 | – | 450,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $16,255,471 | 100.00% |
| CPMG Inc | 8,218,467 | $3,517,504 | 1.92% |
| Western Standard LLC | 1,796,987 | $769,110 | 0.70% |
| Vivo Capital, LLC | 12,486,787 | $5,344,345 | 0.59% |
| Nantahala Capital Management | 1,000,000 | $428,000 | 0.04% |
| Baker Brothers Advisors | 4,704,395 | $2,013,481 | 0.01% |
| HCR Wealth Advisors | 40,000 | $17,120 | 0.00% |
| Hennion & Walsh Asset Management, Inc. | 98,080 | $41,978 | 0.00% |
| Long Focus Capital Management, LLC | 100,000 | $42,800 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 867,279 | $371,195 | 0.00% |